Kevin D. Bunker Zentalis Pharmaceuticals, Inc. (ZNTL) insider trading activity

Kevin D. Bunker is Chief Scientific Officer of Zentalis Pharmaceuticals, Inc.. Currently has a direct ownership of 834,931 shares of ZNTL, which is worth approximately $2.66 Million. The most recent transaction as insider was on Dec 20, 2023, when has been sold 24,158 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 835K

0% 3M change

2.81% 12M change

Total Value Held $2.66 Million

Kevin D. Bunker Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 20 2023	SELL Bona fide gift	-	24,158 Reduced 2.81%	834,931 Common Stock
Oct 04 2023	SELL Open market or private sale	$119,357 $19.67 p/Share	6,068 Reduced 0.7%	859,089 Common Stock
Feb 14 2023	SELL Open market or private sale	$129,870 $19.98 p/Share	6,500 Reduced 0.75%	865,157 Common Stock
Feb 13 2023	SELL Open market or private sale	$77,738 $20.42 p/Share	3,807 Reduced 0.43%	871,657 Common Stock
Feb 01 2023	BUY Grant, award, or other acquisition	-	91,354 Added 9.45%	875,464 Common Stock
Nov 09 2022	SELL Bona fide gift	-	30,000 Reduced 3.69%	784,110 Common Stock
Oct 03 2022	BUY Grant, award, or other acquisition	-	50,000 Added 5.79%	814,110 Common Stock
Feb 14 2022	SELL Open market or private sale	$236,275 $50.4 p/Share	4,688 Reduced 0.61%	764,110 Common Stock
Feb 10 2022	BUY Grant, award, or other acquisition	-	22,481 Added 2.84%	768,798 Common Stock
Dec 30 2021	SELL Bona fide gift	-	8,750 Reduced 1.16%	746,317 Common Stock
Nov 09 2021	SELL Bona fide gift	-	240,000 Reduced 24.12%	755,067 Common Stock
Sep 24 2021	SELL Bona fide gift	-	350 Reduced 0.04%	995,067 Common Stock
Jul 07 2021	SELL Open market or private sale	$212,339 $47.04 p/Share	4,514 Reduced 0.45%	1,008,788 Common Stock
Jul 06 2021	SELL Open market or private sale	$968,012 $47.69 p/Share	20,298 Reduced 2.0%	994,841 Common Stock
Apr 06 2021	SELL Open market or private sale	$11,896 $43.26 p/Share	275 Reduced 0.03%	1,019,653 Common Stock
Apr 05 2021	SELL Open market or private sale	$1,079,584 $44.0 p/Share	24,536 Reduced 2.35%	1,019,928 Common Stock
Feb 11 2021	BUY Grant, award, or other acquisition	-	18,750 Added 1.76%	1,044,464 Common Stock
Jan 04 2021	SELL Open market or private sale	$1,376,436 $51.81 p/Share	26,567 Reduced 2.52%	1,025,713 Common Stock
Dec 24 2020	SELL Bona fide gift	-	1,600 Reduced 0.15%	1,052,280 Common Stock
Dec 07 2020	SELL Open market or private sale	$575,860 $52.87 p/Share	10,892 Reduced 1.02%	1,053,880 Common Stock
Dec 04 2020	SELL Open market or private sale	$619,928 $50.96 p/Share	12,165 Reduced 1.13%	1,064,772 Common Stock
Nov 23 2020	SELL Bona fide gift	-	101,045 Reduced 8.58%	1,076,937 Common Stock
Apr 07 2020	BUY Open market or private purchase	$6,300 $18.0 p/Share	350 Added 0.03%	1,177,982 Common Stock

KDB

Kevin D. Bunker

Chief Scientific Officer

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZNTL shares.

Notify only if

Value

Insider Trading

Get notified when an Zentalis Pharmaceuticals, Inc. insider buys or sells ZNTL shares.

Notify only if

Operation

Value

Type

News

Receive news related to Zentalis Pharmaceuticals, Inc.

Track Activities on ZNTL

Account